Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
Vivek
Nov 9, 2023, 18:04 |
Blog
Vivek Subbiah: Zhen, is that pin in your suit for Disney 100?
Vivek Subbiah, Chief of Early-Phase Drug Development at Sarah Cannon Research Institute, shared on LinkedIn:…
Nov 6, 2023, 22:47 |
Blog
Vivek Subbiah: We've been to the moon, now we need to go to Mars and beyond to eradicate cancer
Vivek Subbiah, posted the following on Twitter: What is the best way to spend that extra…
Nov 6, 2023, 03:26 |
Blog
Vivek Subbiah: How to build a successful phase 1 program?
Vivek Subbiah posted the following on X/Twitter: "How to build a successful phase 1 program? -…
Nov 2, 2023, 18:35 |
Blog
Vivek S. Radhakrishnan: We have provided a comprehensive and contemporary review of immunotherapy in Hodgkin lymphoma
Vivek S. Radhakrishnan, Haematologic Oncologist at Cancer Care Group University Hospital of Southampton, recently shared…
Nov 2, 2023, 00:48 |
Blog
Vivek Subbiah: Wow! What an amazing event on “Shaping the future of personalised healthcare for cancer patients”
Vivek Subbiah, posted the following on LinkedIn: "Wow! What an amazing event on 'Shaping the…
Oct 18, 2023, 18:00 |
Drugs
Vivek Subbiah: My perspectives of tumor agnostic drug development
Vivek Subbiah recently shared on LinkedIn: "So honored to present the “Future of Tissue-Agnostic Precision…
Oct 18, 2023, 16:54 |
Drugs
Vivek Subbiah: Final efficacy and safety results of the ROAR phase 2 basket trial of dabrafenib in eight cohorts of patients with BRAFV600E-mutated advanced rare cancers
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on…
Oct 17, 2023, 01:32 |
Blog
Vivek Subbiah: Awesome poster presentation on Epha2 targeting by our amazing Dr. Elisa Fontana
Vivek Subbiah shared on LinkedIn: "Kudos to our amazing Sarah Cannon Research Institute Phase 1 clinical…
Oct 9, 2023, 18:18 |
Blog
Vivek Subbiah: Mark your calendars if you are attending the NCI AACR EORTC 2023- The triple meeting in Boston, Oct 11-15.
Vivek Subbiah shared on LinkedIn: “Mark your calendars if you are attending the NCI AACR…
Oct 5, 2023, 17:42 |
Insight
Vivek Subbiah: Still remember the 1st ever patient enrolled on the trial in the peak of the pandemic.
Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at The Sarah Cannon Research Institute, on…
18
19
20
21
22
All:
301
Posts:
191 - 200
Highlights on the U.S. - India Cancer Moonshot Dialogue
The Nobel Prize: "Without him my kids wouldn’t be here" - cancer survivor Sharon Belvin
The plight of cancer patients in war-torn regions highlight the urgent need for our collective support - UICC
Top 100 Xfluencers in Sarcoma: Key Opinion Leaders to follow on X (Twitter) in 2024
A Manifesto to Improve Cancer Care in Conflict-Affected Areas: The Lancet
Facebook
RSS Feed
Twitter
Linkedin
Youtube